Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors [Oncotarget, 6, 30, (2015) (30194-30211)] doi: 10.18632/oncotarget.4734

Eusebio S. Pires, Ryan S. D'Souza, Marisa A. Needham, Austin K. Herr, Amir A. Jazaeri, Hui Li, Mark H. Stoler, Kiley L. Anderson-Knapp, Theodore Thomas, Arabinda Mandal, Alain Gougeon, Charles J. Flickinger, David E. Bruns, Brian A. Pollok, John C. Herr

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Correction: Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumors [Oncotarget, 6, 30, (2015) (30194-30211)] doi: 10.18632/oncotarget.4734'. Together they form a unique fingerprint.

Medicine & Life Sciences